# Ultra-stable Iodized Oil-Chemo Embolization Seq Thermal Ablation in Early Liver Ca

> **NCT07493070** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Fujian Medical University Union Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **PROCEDURE:** TACE combined with thermal ablation

## Key facts

- **NCT ID:** NCT07493070
- **Lead sponsor:** Fujian Medical University Union Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-02-10
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-11-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07493070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07493070, "Ultra-stable Iodized Oil-Chemo Embolization Seq Thermal Ablation in Early Liver Ca". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07493070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*